B
Brecht Guillemyn
Researcher at Ghent University Hospital
Publications - 16
Citations - 271
Brecht Guillemyn is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Osteogenesis imperfecta & Compound heterozygosity. The author has an hindex of 6, co-authored 15 publications receiving 184 citations.
Papers
More filters
Journal ArticleDOI
Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa
Tim Van Damme,Thatjana Gardeitchik,Miski Mohamed,Sergio Guerrero-Castillo,Peter Freisinger,Brecht Guillemyn,Ariana Kariminejad,Daisy Dalloyaux,Sanne van Kraaij,Dirk Lefeber,Delfien Syx,Wouter Steyaert,Riet De Rycke,Alexander Hoischen,Erik-Jan Kamsteeg,Sunnie Wong,Monique van Scherpenzeel,Payman Jamali,Ulrich Brandt,Leo G.J. Nijtmans,G. Christoph Korenke,Brian H.Y. Chung,Christopher C.Y. Mak,Ingrid Hausser,Uwe Kornak,Uwe Kornak,Björn Fischer-Zirnsak,Björn Fischer-Zirnsak,Tim M. Strom,Thomas Meitinger,Yasemin Alanay,Gülen Eda Utine,Peter K.C. Leung,Siavash Ghaderi-Sohi,Paul Coucke,Sofie Symoens,Anne De Paepe,Christian Thiel,Tobias B. Haack,Tobias B. Haack,Fransiska Malfait,Eva Morava,Eva Morava,Bert Callewaert,Ron A. Wevers +44 more
TL;DR: These findings expand the clinical and molecular spectrum of metabolic cutis laxa syndromes and further link defective extracellular matrix assembly to faulty protein processing and cellular trafficking caused by genetic defects in the V-ATPase complex.
Journal ArticleDOI
Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to Biallelic BMP1 Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta.
Delfien Syx,Brecht Guillemyn,Sofie Symoens,Ana Berta Sousa,Ana Medeira,Margo L. Whiteford,Trinh Hermanns-Lê,Paul Coucke,Anne De Paepe,Fransiska Malfait +9 more
TL;DR: It is shown that BMP1/mTLD‐deficiency in humans not only results in delayed cleavage of the type I procollagen C‐propeptide but also hampers the processing of the small leucine‐rich proteoglycan prodecorin, a regulator of collagen fibrillogenesis.
Journal ArticleDOI
Biallelic B3GALT6 mutations cause spondylodysplastic Ehlers-Danlos syndrome.
Tim Van Damme,Xiaomeng Pang,Brecht Guillemyn,Sandrine Gulberti,Delfien Syx,Riet De Rycke,Olivier Kaye,Christine E. M. de Die-Smulders,Rolph Pfundt,Ariana Kariminejad,Sheela Nampoothiri,Geneviève Pierquin,Saskia Bulk,Austin Larson,Kathryn C. Chatfield,Marleen Simon,Anne Legrand,Marion Gérard,Sofie Symoens,Sylvie Fournel-Gigleux,Fransiska Malfait +20 more
TL;DR: The phenotype associated with B3GALT6 mutations is redefined on the basis of clinical, molecular and biochemical data in 12 patients, and an in‐depth assessment of &bgr;3GalT6 activity and GAG synthesis to better understand this rare condition.
Journal ArticleDOI
Genetic Defects in TAPT1 Disrupt Ciliogenesis and Cause a Complex Lethal Osteochondrodysplasia
Sofie Symoens,Aileen M. Barnes,Charlotte Gistelinck,Fransiska Malfait,Brecht Guillemyn,Wouter Steyaert,Delfien Syx,Sanne D'hondt,Martine Biervliet,Julie De Backer,Eckhard Witten,Sergey Leikin,Elena Makareeva,Gabriele Gillessen-Kaesbach,Ann Huysseune,Kris Vleminckx,Kris Vleminckx,Andy Willaert,Anne De Paepe,Joan C. Marini,Paul Coucke +20 more
TL;DR: It is demonstrated that TAPT1 mutations underlie a complex congenital syndrome, showing clinical overlap between lethal skeletal dysplasias and ciliopathies, and Knockdown of tapt1b in zebrafish induces severe craniofacial cartilage malformations and delayed ossification, which is shown to be associated with aberrant differentiation of cranial neural crest cells.
Journal ArticleDOI
A homozygous pathogenic missense variant broadens the phenotypic and mutational spectrum of CREB3L1-related osteogenesis imperfecta
Brecht Guillemyn,Hülya Kayserili,Lynn Demuynck,Patrick Sips,Anne De Paepe,Delfien Syx,Paul Coucke,Fransiska Malfait,Sofie Symoens +8 more
TL;DR: The first homozygous pathogenic missense variant is identified in a patient with lethal OI, which is located within the highly conserved basic leucine zipper domain, four amino acids upstream of the DNA binding domain, and affects a critical residue in this functional domain, thereby decreasing the type I collagen transcriptional binding ability.